Company / Financials
PLUS THERAPEUTICS, INC. Financials
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$5.8M
FY2025 · +18.5% YoY
Net Income
-$13.0M
FY2025 · +2.5% YoY
Profit Margin
-222.8%
FY2025 · net income / revenue
ROE
-
FY2025 · return on equity
Total Assets
$16.3M
FY2025
Total Debt
-
FY2025
Equity
-$8.9M
FY2025
ROA
-79.5%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$5.8M+18.5% YoYNet Income HistoryProfit after all expenses and taxes-$13.0M+2.5% YoYGross Profit HistoryRevenue minus cost of goods sold-Cost of Revenue HistoryDirect costs of producing goods and services sold-Operating Income HistoryProfit from core business operations before interest and taxes-$14.7M-10.3% YoYSG&A Expense HistorySelling, general, and administrative expenses$9.9M+16.3% YoYR&D Expense HistoryResearch and development spending$10.6M+9.2% YoYInterest Expense HistoryCost of borrowing and debt obligations-Income Tax HistoryTotal income tax expense$0EPS (Basic) HistoryBasic earnings per share-$1.95+54.0% YoY